# The Pennant Group Inc. (PNTG) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Healthcare / Health Care Providers. Price $41.19, market value $1.4 billion.

## Valuation
- **P/E (trailing): 44.3×** (5-yr avg 81.9×, 3-yr avg 34.3×). The Pennant Group Inc. trades at 44.3× trailing earnings, well below its own five-year average of 81.9×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 26.0×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 1.30**. A PEG of 1.30 is in the range usually read as fairly priced for its growth.
- **Price / sales: 1.3×**. Each dollar of revenue is priced at 1.3×.
- **Price / book: 4.0×**. The shares trade at 4.0× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 22.3×**. Enterprise value is 22.3× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: 2.4%** (5-yr avg 1.6%). Free cash flow equals 2.4% of the market value, above its five-year average of 1.6%, so the shares are cheaper on cash than they have usually been.
- **Earnings yield: 2.3%**. The inverse of the P/E: 2.3% of the price is earned each year.

## Profitability
- **Operating margin: 5.6%**. 5.6% of revenue is left after running the business.
- **Net margin: 3.1%**. 3.1% of each dollar of sales reaches the bottom line.
- **Return on equity: 7.9%**. 7.9% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 9.0%**. Return on all capital, debt included, is 9.0%.
- **Return on assets: 3.3%**. Each dollar of assets produces 3.3% of profit.

## Growth
- **Revenue growth (1 yr): 36.3%** (3-yr 26.0%/yr, 5-yr 19.4%/yr). Revenue grew 36.3% over the last year, against 19.4% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 20.0%** (3-yr 56.3%/yr, 5-yr 10.1%/yr). Earnings per share rose 20.0%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.46**. Debt is 0.46 times equity: a conservative balance sheet.
- **Current ratio: 1.14** (quick 1.14). Current assets cover the next year's liabilities 1.14 times.
- **Altman Z-score: 3.18**. A Z-score of 3.18 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. The Pennant Group Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (6 analysts). 6 analysts cover The Pennant Group Inc.; the consensus is strong_buy, with an average price target of $46.83 (+14% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 63.8%** (YTD 43.9%, 3-mo 0.8%). The shares are up 63.8% over twelve months including dividends.
- **From 52-week high: -5.1%** (85.1% above the low). Trading 5% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 47**. An RSI of 47 is neutral.
- **Beta (1 yr): 0.21** (volatility 38%). Beta of 0.21 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=PNTG · Page: https://foliofundamentals.com/stocks/pntg

Not investment advice.